New RSV vaccine for moms: safe for baby too?
NCT ID NCT06482099
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 37 times
Summary
This study looked at the safety of the RSV vaccine Abrysvo in pregnant women and their infants in Japan. About 500 pregnant women received the vaccine, and researchers tracked any side effects in the mothers for 28 days after vaccination and in the babies for 28 days after birth. The goal was to confirm the vaccine's safety in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.